Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (191-200 of 567) with videos related to

Pageof 57
Sort By:
American Heart Journal|July 1, 1999
Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary ArteriesD Hasdai, D R Holmes, R M Califf, et al.
Circulation|November 16, 1999
Clinical outcomes of bivalirudin for ischemic heart diseaseD F Kong, E J Topol, J A Bittl, et al.
Circulation|November 1, 1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study GroupD C Stump, R M Califf, E J Topol, et al.
Diabetes, Obesity & Metabolism|January 21, 2015
Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)M A Bethel, J B Green, J Milton, et al.
Journal of the American College of Cardiology|June 1, 1995
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesA Langer, M W Krucoff, P Klootwijk, et al.
The American Journal of Cardiology|February 15, 1985
Analysis of risk factors for sudden death after acute myocardial infarctionF E Harrell, K L Lee, R A McKinnis, et al.
Journal of the American College of Cardiology|March 15, 1993
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupC B Granger, R M Califf, S Young, et al.
Circulation|April 1, 1991
Identification of acute myocardial infarction patients suitable for early hospital discharge after aggressive interventional therapy. Results from the Thrombolysis and Angioplasty in Acute Myocardial Infarction RegistryD B Mark, K Sigmon, E J Topol, et al.
The American Journal of Cardiology|May 1, 1997
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary ArteriesT S Tsang, R M Califf, A L Stebbins, et al.
Journal of Electrocardiology|May 20, 2000
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyK M Akkerhuis, A C Maas, P A Klootwijk, et al.
Pageof 57

Showing results (191-200 of 567) with videos related to

Sort By:
Pageof 57
American Heart Journal|July 1, 1999
Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary ArteriesD Hasdai, D R Holmes, R M Califf, et al.
Circulation|November 16, 1999
Clinical outcomes of bivalirudin for ischemic heart diseaseD F Kong, E J Topol, J A Bittl, et al.
Circulation|November 1, 1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study GroupD C Stump, R M Califf, E J Topol, et al.
Diabetes, Obesity & Metabolism|January 21, 2015
Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)M A Bethel, J B Green, J Milton, et al.
Journal of the American College of Cardiology|June 1, 1995
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesA Langer, M W Krucoff, P Klootwijk, et al.
The American Journal of Cardiology|February 15, 1985
Analysis of risk factors for sudden death after acute myocardial infarctionF E Harrell, K L Lee, R A McKinnis, et al.
Journal of the American College of Cardiology|March 15, 1993
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupC B Granger, R M Califf, S Young, et al.
Circulation|April 1, 1991
Identification of acute myocardial infarction patients suitable for early hospital discharge after aggressive interventional therapy. Results from the Thrombolysis and Angioplasty in Acute Myocardial Infarction RegistryD B Mark, K Sigmon, E J Topol, et al.
The American Journal of Cardiology|May 1, 1997
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary ArteriesT S Tsang, R M Califf, A L Stebbins, et al.
Journal of Electrocardiology|May 20, 2000
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyK M Akkerhuis, A C Maas, P A Klootwijk, et al.
Pageof 57